Effects of the Davos Alzheimer's Collaborative early detection of cognitive impairment program on clinician attitudes, engagement, and confidence

The implementation of digital cognitive assessment tools and a blood biomarker test was associated with an increase in healthcare professionals' confidence in diagnosing and managing patients with cognitive impairment in primary care and non-specialty settings. Digital cognitive assessments and blood biomarker tests are promising tools that could be utilized in primary care to increase clinicians' confidence in detecting dementia and lead to timely clinical evaluation, treatment, and referral to supportive resources.

Authors

Institutions

Publication Details

Journal
The Journal of Prevention of Alzheimer s Disease
Published
2025-02-04
DOI
https://doi.org/10.1016/j.tjpad.2024.100038
Citations
5
Primary Topic
Dementia and Cognitive Impairment Research
Type
article
Field-Weighted Citation Impact
7.36

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Effects of the Davos Alzheimer's Collaborative early detection of cognitive impairment program on clinician attitudes, engagement, and confidence

Magda R. Baksh, Katherine J. Selzler, Nicole R. Fowler, Otelo Corrêa dos Santos Filho et al.
5 citations
The Journal of Prevention of Alzheimer s Disease
Dementia and Cognitive Impairment Research
7.36
article

Effects of the Davos Alzheimer's Collaborative early detection of cognitive impairment program on clinician attitudes, engagement, and confidence

Magda R. Baksh, Katherine J. Selzler, Nicole R. Fowler, Otelo Corrêa dos Santos Filho, Daniel Ball, Soeren Mattke, Hisatomo Kowa, Janelle N. Robinson, Deanna Willis, Amy Deckert, Alastair J. McKean, Steven R. Smith, T Ozawa, Ishtar Govia, Tim MacLeod, Mariana López‐Ortega, W. A. Chambers
article en
5 citations

Abstract

The implementation of digital cognitive assessment tools and a blood biomarker test was associated with an increase in healthcare professionals' confidence in diagnosing and managing patients with cognitive impairment in primary care and non-specialty settings. Digital cognitive assessments and blood biomarker tests are promising tools that could be utilized in primary care to increase clinicians' confidence in detecting dementia and lead to timely clinical evaluation, treatment, and referral to supportive resources.

The Journal of Prevention of Alzheimer s DiseaseVol. 12(3)
Kobe Design University (JP), University of Southern California (US), The Graduate Center, CUNY (US), Regenstrief Institute (US), AdventHealth Orlando (US), AdventHealth East Orlando (US), NHS Dumfries and Galloway (GB), Universidade do Estado do Rio de Janeiro (BR), Alzheimer’s Disease Neuroimaging Initiative (US), Public Health Scotland (GB), Vietnam National Children's Hospital (VN), Indiana University – Purdue University Indianapolis (US), University of Technology, Jamaica (JM), Kobe University (JP)
School of Medicine, Indiana University
Reduced inequalities
Openalex Percentile: Top 3%
Dementia and Cognitive Impairment Research
7.36
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.